MEDICAL PREDICTIVE SCIENCE CORPORATION
Clinical decision support software dashboard that aggregates neonatal nutrition and fluid intake data and models projected growth based on nutrition intake and physiologic parameters.
- Sector
- Digital health
- Headquarters
- CHARLOTTESVILLE, VA
- Latest Form D
- $1.3M, Nov 2010
- Total capital
- $1.5M
- Federal grants
- $261K
- 1 award · 2022
- Sector median 0 awards
- Private capital raised
- $1.3M
- 1 Form D · last Nov 2010
- 191 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Clinical Decision Support System to Optimize Neonatal Nutrition and Growth$261K
- Private capital raisedForm D · SEC · 1st filing$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Charles W. MoormanDirectorNamed in SEC Form D filings
- Geoffrey R. AlmsExecutive OfficerNamed in SEC Form D filings
- James W. NewmanDirectorNamed in SEC Form D filings
- Mark W. KrebsDirectorNamed in SEC Form D filings
- Scott D. BoothExecutive OfficerNamed in SEC Form D filings
- Will E KingExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingMethod, System and Device for Individualized Supplemental Oxygen Therapy for Preterm InfantsUSPTOApplication 18140973
- PendingMethod, System And Device For Individualized Supplemental Oxygen Therapy For Preterm InfantsUSPTOApplication PCTUS2023024530
Recent research by its founders
- Modeling heart rate patterns to quantify neonatal opioid withdrawal syndrome20260 cites
- Temporal trends in heart rate characteristic index preceding necrotizing enterocolitis in preterm infants20260 cites
- Heart rate characteristics predict risk of mortality in preterm infants in low and high target oxygen saturation ranges20241 cites
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .